APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Eluting Beads

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug Eluting Beads Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchDrug Eluting Beads Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Eluting Beads Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Drug Eluting Beads Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Eluting Beads Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Eluting Beads Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Drug Eluting Beads market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drug Eluting Beads is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug Eluting Beads is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug Eluting Beads is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug Eluting Beads is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug Eluting Beads include Medtronic, Terumo, Surefire Medical, Merit Medical Systems, Merit Medical Systems, CeloNova BioSciences, BTG International, Boston Scientific and Biocompatibles, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drug Eluting Beads market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug Eluting Beads and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug Eluting Beads sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug Eluting Beads market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug Eluting Beads Segment by Company

Medtronic

Terumo

Surefire Medical

Merit Medical Systems

Merit Medical Systems

CeloNova BioSciences

BTG International

Boston Scientific

Biocompatibles

ABK Biomedical

Drug Eluting Beads Segment by Type

LC Beads

Quadra Sphere

Oncozene Beads

Others

Drug Eluting Beads Segment by Application

Specialized Clinics

Hospitals

Research Centers

Ambulatory Surgical Centers

Drug Eluting Beads Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Beads market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Eluting Beads and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Beads.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug Eluting Beads market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug Eluting Beads manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drug Eluting Beads in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drug Eluting Beads in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drug Eluting Beads Industry Trends Table 2. Drug Eluting Beads Industry Drivers Table 3. Drug Eluting Beads Industry Opportunities and Challenges Table 4. Drug Eluting Beads Industry Restraints Table 5. Global Drug Eluting Beads Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drug Eluting Beads Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drug Eluting Beads Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Drug Eluting Beads Sales Market Share by Manufacturers Table 9. Global Drug Eluting Beads Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Drug Eluting Beads Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drug Eluting Beads Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drug Eluting Beads Manufacturers, Product Type & Application Table 13. Global Drug Eluting Beads Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drug Eluting Beads by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of LC Beads Table 17. Major Manufacturers of Quadra Sphere Table 18. Major Manufacturers of Oncozene Beads Table 19. Major Manufacturers of Others Table 20. Global Drug Eluting Beads Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Drug Eluting Beads Sales by Type (2021-2026) & (k units) Table 22. Global Drug Eluting Beads Sales by Type (2027-2032) & (k units) Table 23. Global Drug Eluting Beads Sales Market Share by Type (2021-2026) Table 24. Global Drug Eluting Beads Sales Market Share by Type (2027-2032) Table 25. Global Drug Eluting Beads Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Drug Eluting Beads Revenue by Type (2021-2026) & (k units) Table 27. Global Drug Eluting Beads Revenue by Type (2027-2032) & (k units) Table 28. Global Drug Eluting Beads Revenue Market Share by Type (2021-2026) Table 29. Global Drug Eluting Beads Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Specialized Clinics Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Research Centers Table 33. Major Manufacturers of Ambulatory Surgical Centers Table 34. Global Drug Eluting Beads Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Drug Eluting Beads Sales by Application (2021-2026) & (k units) Table 36. Global Drug Eluting Beads Sales by Application (2027-2032) & (k units) Table 37. Global Drug Eluting Beads Sales Market Share by Application (2021-2026) Table 38. Global Drug Eluting Beads Sales Market Share by Application (2027-2032) Table 39. Global Drug Eluting Beads Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Drug Eluting Beads Revenue by Application (2021-2026) & (k units) Table 41. Global Drug Eluting Beads Revenue by Application (2027-2032) & (k units) Table 42. Global Drug Eluting Beads Revenue Market Share by Application (2021-2026) Table 43. Global Drug Eluting Beads Revenue Market Share by Application (2027-2032) Table 44. Global Drug Eluting Beads Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Drug Eluting Beads Sales by Region (2021-2026) & (k units) Table 46. Global Drug Eluting Beads Sales Market Share by Region (2021-2026) Table 47. Global Drug Eluting Beads Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Drug Eluting Beads Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Drug Eluting Beads Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Drug Eluting Beads Sales by Country (2021-2026) & (k units) Table 51. North America Drug Eluting Beads Sales by Country (2027-2032) & (k units) Table 52. Europe Drug Eluting Beads Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Drug Eluting Beads Sales by Country (2021-2026) & (k units) Table 54. Europe Drug Eluting Beads Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Drug Eluting Beads Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Drug Eluting Beads Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Drug Eluting Beads Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Drug Eluting Beads Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Drug Eluting Beads Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Drug Eluting Beads Sales by Country (2027-2032) & (k units) Table 61. Global Drug Eluting Beads Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Drug Eluting Beads Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Drug Eluting Beads Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Drug Eluting Beads Revenue Market Share by Region (2021-2026) Table 65. Global Drug Eluting Beads Revenue Market Share by Region (2027-2032) Table 66. Medtronic Company Information Table 67. Medtronic Business Overview Table 68. Medtronic Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Medtronic Drug Eluting Beads Product Portfolio Table 70. Medtronic Recent Development Table 71. Terumo Company Information Table 72. Terumo Business Overview Table 73. Terumo Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Terumo Drug Eluting Beads Product Portfolio Table 75. Terumo Recent Development Table 76. Surefire Medical Company Information Table 77. Surefire Medical Business Overview Table 78. Surefire Medical Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Surefire Medical Drug Eluting Beads Product Portfolio Table 80. Surefire Medical Recent Development Table 81. Merit Medical Systems Company Information Table 82. Merit Medical Systems Business Overview Table 83. Merit Medical Systems Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Merit Medical Systems Drug Eluting Beads Product Portfolio Table 85. Merit Medical Systems Recent Development Table 86. Merit Medical Systems Company Information Table 87. Merit Medical Systems Business Overview Table 88. Merit Medical Systems Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Merit Medical Systems Drug Eluting Beads Product Portfolio Table 90. Merit Medical Systems Recent Development Table 91. CeloNova BioSciences Company Information Table 92. CeloNova BioSciences Business Overview Table 93. CeloNova BioSciences Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. CeloNova BioSciences Drug Eluting Beads Product Portfolio Table 95. CeloNova BioSciences Recent Development Table 96. BTG International Company Information Table 97. BTG International Business Overview Table 98. BTG International Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. BTG International Drug Eluting Beads Product Portfolio Table 100. BTG International Recent Development Table 101. Boston Scientific Company Information Table 102. Boston Scientific Business Overview Table 103. Boston Scientific Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Boston Scientific Drug Eluting Beads Product Portfolio Table 105. Boston Scientific Recent Development Table 106. Biocompatibles Company Information Table 107. Biocompatibles Business Overview Table 108. Biocompatibles Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Biocompatibles Drug Eluting Beads Product Portfolio Table 110. Biocompatibles Recent Development Table 111. ABK Biomedical Company Information Table 112. ABK Biomedical Business Overview Table 113. ABK Biomedical Drug Eluting Beads Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. ABK Biomedical Drug Eluting Beads Product Portfolio Table 115. ABK Biomedical Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Drug Eluting Beads Distributors List Table 119. Drug Eluting Beads Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Drug Eluting Beads Product Image Figure 2. Global Drug Eluting Beads Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Eluting Beads Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug Eluting Beads Sales (2021-2032) & (k units) Figure 5. Global Drug Eluting Beads Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drug Eluting Beads Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. LC Beads Image Figure 9. Quadra Sphere Image Figure 10. Oncozene Beads Image Figure 11. Others Image Figure 12. Global Drug Eluting Beads Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Drug Eluting Beads Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Drug Eluting Beads Sales Market Share by Type (2021-2032) Figure 15. Global Drug Eluting Beads Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Drug Eluting Beads Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Drug Eluting Beads Revenue Market Share by Type (2021-2032) Figure 18. Specialized Clinics Image Figure 19. Hospitals Image Figure 20. Research Centers Image Figure 21. Ambulatory Surgical Centers Image Figure 22. Global Drug Eluting Beads Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Drug Eluting Beads Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Drug Eluting Beads Sales Market Share by Application (2021-2032) Figure 25. Global Drug Eluting Beads Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Drug Eluting Beads Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Drug Eluting Beads Revenue Market Share by Application (2021-2032) Figure 28. North America Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Drug Eluting Beads Sales Market Share by Country (2021-2032) Figure 30. U.S. Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Drug Eluting Beads Sales Market Share by Country (2021-2032) Figure 35. Germany Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Drug Eluting Beads Sales Market Share by Country (2021-2032) Figure 42. China Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Drug Eluting Beads Sales Market Share by Country (2021-2032) Figure 50. Brazil Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Drug Eluting Beads Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Drug Eluting Beads Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Drug Eluting Beads Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Drug Eluting Beads Revenue (2021-2032) & (US$ Million) Figure 61. North America Drug Eluting Beads Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Drug Eluting Beads Revenue (2021-2032) & (US$ Million) Figure 63. Europe Drug Eluting Beads Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Drug Eluting Beads Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Drug Eluting Beads Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Drug Eluting Beads Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Drug Eluting Beads Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Drug Eluting Beads Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Drug Eluting Beads Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • LC Beads
  • Quadra Sphere
  • Oncozene Beads
  • Others
Applications
  • Specialized Clinics
  • Hospitals
  • Research Centers
  • Ambulatory Surgical Centers
Companies covered
  • Medtronic
  • Terumo
  • Surefire Medical
  • Merit Medical Systems
  • Merit Medical Systems
  • CeloNova BioSciences
  • BTG International
  • Boston Scientific
  • Biocompatibles
  • ABK Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug Eluting Beads Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug Eluting Beads Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drug Eluting Beads Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drug Eluting Beads Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drug Eluting Beads Market Dynamics
  1. 2.1 Drug Eluting Beads Industry Trends
  2. 2.2 Drug Eluting Beads Industry Drivers
  3. 2.3 Drug Eluting Beads Industry Opportunities and Challenges
  4. 2.4 Drug Eluting Beads Industry Restraints
3 Drug Eluting Beads Market by Manufacturers
  1. 3.1 Global Drug Eluting Beads Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drug Eluting Beads Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drug Eluting Beads Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drug Eluting Beads Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug Eluting Beads Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drug Eluting Beads Manufacturers, Product Type & Application
  7. 3.7 Global Drug Eluting Beads Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug Eluting Beads Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug Eluting Beads Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug Eluting Beads Tier 1, Tier 2, and Tier 3
4 Drug Eluting Beads Market by Type
  1. 4.1 Drug Eluting Beads Type Introduction
  2. 4.1.1 LC Beads
  3. 4.1.2 Quadra Sphere
  4. 4.1.3 Oncozene Beads
  5. 4.1.4 Others
  6. 4.2 Global Drug Eluting Beads Sales by Type
  7. 4.2.1 Global Drug Eluting Beads Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Drug Eluting Beads Sales by Type (2021-2032)
  9. 4.2.3 Global Drug Eluting Beads Sales Market Share by Type (2021-2032)
  10. 4.3 Global Drug Eluting Beads Revenue by Type
  11. 4.3.1 Global Drug Eluting Beads Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Drug Eluting Beads Revenue by Type (2021-2032)
  13. 4.3.3 Global Drug Eluting Beads Revenue Market Share by Type (2021-2032)
5 Drug Eluting Beads Market by Application
  1. 5.1 Drug Eluting Beads Application Introduction
  2. 5.1.1 Specialized Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Research Centers
  5. 5.1.4 Ambulatory Surgical Centers
  6. 5.2 Global Drug Eluting Beads Sales by Application
  7. 5.2.1 Global Drug Eluting Beads Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Drug Eluting Beads Sales by Application (2021-2032)
  9. 5.2.3 Global Drug Eluting Beads Sales Market Share by Application (2021-2032)
  10. 5.3 Global Drug Eluting Beads Revenue by Application
  11. 5.3.1 Global Drug Eluting Beads Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Drug Eluting Beads Revenue by Application (2021-2032)
  13. 5.3.3 Global Drug Eluting Beads Revenue Market Share by Application (2021-2032)
6 Global Drug Eluting Beads Sales by Region
  1. 6.1 Global Drug Eluting Beads Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug Eluting Beads Sales by Region (2021-2032)
  3. 6.2.1 Global Drug Eluting Beads Sales by Region (2021-2026)
  4. 6.2.2 Global Drug Eluting Beads Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug Eluting Beads Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drug Eluting Beads Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drug Eluting Beads Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drug Eluting Beads Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drug Eluting Beads Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drug Eluting Beads Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drug Eluting Beads Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drug Eluting Beads Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drug Eluting Beads Revenue by Region
  1. 7.1 Global Drug Eluting Beads Revenue by Region
  2. 7.1.1 Global Drug Eluting Beads Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drug Eluting Beads Revenue by Region (2021-2026)
  4. 7.1.3 Global Drug Eluting Beads Revenue by Region (2027-2032)
  5. 7.1.4 Global Drug Eluting Beads Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drug Eluting Beads Revenue (2021-2032)
  8. 7.2.2 North America Drug Eluting Beads Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drug Eluting Beads Revenue (2021-2032)
  11. 7.3.2 Europe Drug Eluting Beads Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drug Eluting Beads Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drug Eluting Beads Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drug Eluting Beads Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drug Eluting Beads Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Drug Eluting Beads Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Terumo
  8. 8.2.1 Terumo Company Information
  9. 8.2.2 Terumo Business Overview
  10. 8.2.3 Terumo Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Terumo Drug Eluting Beads Product Portfolio
  12. 8.2.5 Terumo Recent Developments
  13. 8.3 Surefire Medical
  14. 8.3.1 Surefire Medical Company Information
  15. 8.3.2 Surefire Medical Business Overview
  16. 8.3.3 Surefire Medical Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Surefire Medical Drug Eluting Beads Product Portfolio
  18. 8.3.5 Surefire Medical Recent Developments
  19. 8.4 Merit Medical Systems
  20. 8.4.1 Merit Medical Systems Company Information
  21. 8.4.2 Merit Medical Systems Business Overview
  22. 8.4.3 Merit Medical Systems Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
  24. 8.4.5 Merit Medical Systems Recent Developments
  25. 8.5 Merit Medical Systems
  26. 8.5.1 Merit Medical Systems Company Information
  27. 8.5.2 Merit Medical Systems Business Overview
  28. 8.5.3 Merit Medical Systems Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merit Medical Systems Drug Eluting Beads Product Portfolio
  30. 8.5.5 Merit Medical Systems Recent Developments
  31. 8.6 CeloNova BioSciences
  32. 8.6.1 CeloNova BioSciences Company Information
  33. 8.6.2 CeloNova BioSciences Business Overview
  34. 8.6.3 CeloNova BioSciences Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CeloNova BioSciences Drug Eluting Beads Product Portfolio
  36. 8.6.5 CeloNova BioSciences Recent Developments
  37. 8.7 BTG International
  38. 8.7.1 BTG International Company Information
  39. 8.7.2 BTG International Business Overview
  40. 8.7.3 BTG International Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BTG International Drug Eluting Beads Product Portfolio
  42. 8.7.5 BTG International Recent Developments
  43. 8.8 Boston Scientific
  44. 8.8.1 Boston Scientific Company Information
  45. 8.8.2 Boston Scientific Business Overview
  46. 8.8.3 Boston Scientific Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boston Scientific Drug Eluting Beads Product Portfolio
  48. 8.8.5 Boston Scientific Recent Developments
  49. 8.9 Biocompatibles
  50. 8.9.1 Biocompatibles Company Information
  51. 8.9.2 Biocompatibles Business Overview
  52. 8.9.3 Biocompatibles Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Biocompatibles Drug Eluting Beads Product Portfolio
  54. 8.9.5 Biocompatibles Recent Developments
  55. 8.10 ABK Biomedical
  56. 8.10.1 ABK Biomedical Company Information
  57. 8.10.2 ABK Biomedical Business Overview
  58. 8.10.3 ABK Biomedical Drug Eluting Beads Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ABK Biomedical Drug Eluting Beads Product Portfolio
  60. 8.10.5 ABK Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drug Eluting Beads Value Chain Analysis
  2. 9.1.1 Drug Eluting Beads Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drug Eluting Beads Production Mode & Process
  6. 9.2 Drug Eluting Beads Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drug Eluting Beads Distributors
  9. 9.2.3 Drug Eluting Beads Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst